Glycoconjugate vaccines are composed of as ugar antigen covalently linked to ap rotein carrier,and can elicit specific long-lasting immunogenic response toward poorly immunogenic carbohydrates. [1] Currently,a lmost all conjugate vaccines are prepared by random conjugation at lysines or aspartates/glutamates. [2] Recent studies have highlighted ap ossible role for the saccharide-protein connectivity in determining immunogenicity. [3] Emerging site-selective conjugation methods can offer new tools to study this phenomenon. [4] Thef irst attempts at linking saccharide antigens to define sites on the carrier protein have been performed using synthetic oligosaccharides. [5] Our previous findings [5b-d] encouraged us to further elucidate acomprehensive relationship between connectivity and immunogenicity,a nd to define the minimal glycan loading for adefined regioisomeric glycoconjugate.
Meanwhile,weare interested to develop aglycoconjugate vaccines against Salmonella enterica serovar typhimurium, which is one of the most common serovars responsible for invasive nontyphoidal Salmonella (iNTS) disease in Africa, [6] resulting in case fatality rates up to 25 %. [7] Avaccine against S. typhimurium is urgently needed, but not yet available.
Thel ipopolysaccharide O-antigen (OAg) of Salmonella ( Figure 1 ) has been implicated as at arget of protective immunity.
[9] Here we present two novel methods for siteselective glycan conjugation providing conjugates with single attachment sites on the protein, based on disulfide bond chemical modification and pH-controlled transglutaminasecatalyzed reaction at lysine, [10] respectively.Bythese methods and others previously reported, [5b,c] ad iverse set of siteselective derivatizations at disulfide,l ysines,t yrosines,a nd glutamates/aspartates of CRM 197 (Scheme 1) was prepared and as urvey of immunogenicity of various regioisomeric OAg-based glycoconjugate vaccines against S. typhimurium was conducted. [9d, 11] CRM 197 was selected as the carrier protein in the study, because of its defined structure and well-proven clinical validation. [12] Thepreparation of its mutants is challenging, we hence seek for diverse site-controlled conjugation of CRM 197 to enable ac omprehensive structure-activity relationship (SAR) evaluation.
As train-promoted azide-alkyne click reaction (SPAAC) was planned for the introduction of large glycan in the final step.Therefore,azido linkers were introduced at diverse sites on CRM 197 (Scheme 1).
With regard to lysine selective modification, it was found that aCbz-Gln-Gly (ZQG) linker bearing azide is compatible to microbial transglutaminase (mTGase) catalyzed labeling. [10] TheG ln was selectively activated by mTGase and enabled the selective acylationofonly one lysine at pH 8after 18 h. Thep eptide mapping analysis following trypsin digestion indicated only one of K37/39 was labeled. K37/39 is indistinguishable in the limitation of the analytic method. Lowering the reaction pH to 6a nd increasing the reaction time from 18 to 72 hl ed to an increased labeling level, and K33 was found as the additional labeling site besides K37/39 out of atotal of 39 lysines (Scheme 2; Figures S1 and S2).
We next explored single modifications at cysteines,which are paired in two disulfides in CRM 197 .T he C461-C471 bond appeared to be buried inside the protein, and the C186-C201 was surface exposed. CRM 197 was selectively partial reduced Abstract: Aseries of glycoconjugates with defined connectivity were synthesized to investigate the impact of coupling Salmonella typhimurium O-antigen to different amino acids of CRM 197 protein carrier.I np articular,t wo novel methods for site-selective glycan conjugation were developed to obtain conjugates with single attachment site on the protein, based on chemical modification of ad isulfide bond and pH-controlled transglutaminase-catalyzed modification of lysine,r espectively.Importantly,conjugation at the C186-201 bond resulted in significantly higher anti O-antigen bactericidal antibody titers than coupling to K37/39, and in comparable titers to conjugates bearing alarger number of saccharides.This study demonstrates that the conjugation site plays arole in determining the immunogenicity in mice and one single attachment point may be sufficient to induce high levels of bactericidal antibodies. Figure 1 . Structure of the O-antigen chain linked to the core region of 2192 S. typhimurium lipopolysaccharide. [8] [*] G. Stefanetti 
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to release C186 and C201 in the presence of tris(2-carboxyethyl)phosphine (TCEP,6equiv) in sodium phosphate buffer (pH 7.4) at room temperature. Thes ubsequent incubation with 1,3-dichloroacetone (10 equiv) yielded the modified CRM 197 .T he peptide mapping analysis following trypsin digestion gave 80 %sequence coverage of CRM 197 and confirmed that ab ridge-bearing ketone functionality was exclusively formed between C186 and C201, without any detectible C461-C471 crosslinking (see Figure S1 in the Supporting Information). [13] Thea zide was introduced to the modified CRM 197 by oxime formation reaction with an aminooxy-azide bifunctional reagent (Scheme 3; Figure S3 ).
Then we envisaged the modification of few residues. Controlled conjugation to the more surface-exposed lysines, by activation of the amine groups with NHS-PEG 4 -N 3 leads to the introduction of an average number of 7.1 and 3.8 linkers, respectively,o nto CRM 197 (NHS-PEG 4 -N 3 = azide-and Nhydroxysuccinimide-functionalized poly(ethylene glycol);see the Supporting Information).
[5b] In agreement with aprevious report,
[5b] LC-ESI MS/MS analysis of the digested peptides showed that surface-exposed lysine residues were modified more readily than non-surface-exposed ones,w ith preferential modification of as ubset of CRM 197 residues (namely K103, K221, K242, with the further modification of K236, . .
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;L C = liquid chromatography,E SI = electrospray ionization, MS/MS = tandem mass spectrometry). Investigating further the reasons of this selectivity we also found some exceptions.F or example K244 is also surface exposed and minimal modification was observed in contrast to the nearby K242. We noticed that K244 forms asalt bridge with adjacent aspartic acid and has limited flexibility and low nucleophilicity because of the protonated status.H ence,t he availability of the lysine residues appears influenced by the amino acidic contour in addition to the surface exposition.
Thet riazolidinone-ene reaction in tris(hydroxymethyl)-aminomethane (Tris) buffer was employed to selectively target tyrosine residues,resulting in the insertion of an azide moiety at defined sites (see the Supporting Information).
[5d]
By changing the ratio of linker to CRM 197 ,anaverage of 1.5, 2.6, or 3.8 alkyne functional groups were introduced, respectively.L C-ESI MS/MS analysis of proteolytic digests indicated that the surface-exposed Y27, Y46, Y358, and Y380 were the major residues modified out of atotal 18 tyrosines. Fora ll samples,t he recovery of purified protein was consistently larger than 80 %, and analysis by HPLC-SEC showed the presence of only one peak with asimilar retention time to underivatized CRM 197 .
Forc oupling with the protein, OAgw as modified at the terminal KDO sugar. After introduction of an adipic acid dihydrazide (ADH) molecule by reductive amination, [11, 14] as econd linker was introduced with at erminal alkyne group (Scheme 4; see the Supporting Information).
Based on the recently published observation that large polysaccharides cannot be efficiently condensed by coppermediated click chemistry, [15] the strain-promoted azidealkyne cycloaddition variant of this reaction was used for the incorporation of saccharide. [15] [16] Both these steps were characterized by sugar recoveries larger than 80 %a nd activation degrees larger than 90 %.
Copper-free click chemistry allowed linkage of the terminal sugar of the OAgchain to CRM 197 even when few or only one linker were present on the protein (Table S1 ). Even when the number of linkers was increased to an average of seven lysine residues on CRM 197 ,nomore than an average of two OAgc hains per protein was incorporated, as indicated by the molar OAgtoCRM 197 ratio of the obtained conjugate (11 b,T able 1). OAg-CRM 197 10 with one or two glycan moieties were characterized by as imilar sugar-to-protein ratio,c lose to 0.7 ( Table 1) , indicating that even when two linkers were introduced on Scheme 4. Conjugation strategy used for the synthesis of glyconjugates. The terminal KDO unit of the OAg chain (7)w as activated with ADH (8)and then linked to BCN NHS I(9)t ointroduce the alkyne functionality.T he activated OAg was finally conjugated with the azidoderivatized CRM 197 by copper-free click chemistry (10) (11) (12) (13) (14) . Targeting of tyrosine residues for conjugation allowed better control of the OAg/CRM 197 ratio in the corresponding glycoconjugates than targeting lysine residues,w ith the number of OAgc hains introduced per CRM 197 similar to the number of linkers introduced (OAg-CRM 197 12,T able 1). In fact, although the linker loading on tyrosine residues was increased by just af ew units,f rom 1.5 to 2.6 and 4.3, the corresponding carbohydrate loading enhanced from 2.0 to 2.4 to 3.8 respectively,i na greement with what was previously reported. [5c,d] This outcome could be related to the different surface distribution of involved lysine and tyrosine residues on CRM 197 ( Figure S1 ). [5b-d] Particularly when the lysines were targeted, the incorporation of one OAgc hain could challenge the insertion of asecond large glycan moiety by steric hindrance ( Figure S1 ). Thec arboxylic glutamate/aspartate chemistry was characterized by al ow conjugation efficiency, even if an average number of 4.8 azido groups were introduced on the protein, and resulted in ac onjugate with al ow OAg-to-protein ratio (14,T able 1).
All the synthesized conjugates were tested in mice to investigate the impact of OAg-protein specific amino acid connectivity and saccharide-to-protein ratio on the immune response.
Groups of eight mice were immunized at days 0, 28, and 42 with 1 mgO Ag-based dose of conjugates formulated with alhydrogel as adjuvant ( Figure 2a nd the Supporting Information). Notably,atday 56 10 b induced higher anti-OAg IgG responses than 10 a (p = 0.0379), and at day 42 both 10 b and 13 gave significantly higher anti-OAg IgG responses than 10 a (p = 0.0135 and p = 0.0065 respectively). As these constructs possess the same OAg-to-protein ratio,t his result strongly suggests that the position of glycosylation on the protein influences the immunogenicity of glycoconjugates.T he antiOAgIgG response obtained with 11 b was higher than that for 10 a both at day 42 and 56 (p = 0.0153 and p = 0.0353, respectively), but was not significantly different from 10 b and 11 a.C onjugates with higher OAgt oprotein ratio gave comparable immune responses,regardless of the conjugation site.
To test the functional activity of the elicited antibodies, individual mouse sera at day 56 were tested for serum bactericidal activity (SBA) against S. typhimurium D23580, the index invasive Malawian clinical isolate of the ST313 pathovar. [17] All conjugates induced bactericidal antibodies (Table 2a nd the Supporting Information). Theb actericidal activity of sera from mice immunized with conjugates with highest carbohydrate-to-protein ratios (11 b, 12 c,and 14) was similar, regardless of the amino acids involved and the OAgto-CRM 197 ratio.Importantly,OAg-CRM 197 (13)induced sera with 10-fold greater bactericidal activity than 10 a,a nd comparable to the conjugates at higher OAgl oading. The finding suggested the importance of the conjugation site on immunogenicity.I na ddition, the putative presented glycopeptide from 13 might bear two T-epitope peptides as the glycan was linked to two cysteines.T his unique structural feature might contribute to the enhanced immunogenicity of the attached glycan.
Immunogenicity results obtained are consistent with the model recently proposed for glycoconjugate vaccines where glycopeptides have an important role in the B-T cell cooperation. [3] Alternatively,i ti sp lausible to think that different attachment sites could result in 1) diverse exposure/ presentation of the glycoconjugate to antigen presenting cells, 2) different processing of the vaccine inside B-cells,o r 3) formation of different peptides after processing of the conjugates inside B-cells to be presented to T-cells.T he importance of the amino acids targeted in the conjugation reaction is not apparent when random chemical methods are used. Anti-OAg IgG levels among some conjugates characterized by as imilar OAg-to-protein ratio,b ut targeting different amino acids (lysines vs.g lutamates/aspartates and lysines vs.t yrosines) were comparable ( Figure 2) . These results could be explained by an average response which masks the contribution of individual "optimal" positions.
In conclusion, we have developed ad iverse set of siteselective conjugation methods suitable for the synthesis of glyco-CRM 197 ,c onjugates with various carbohydrate loading and attachment points.W ef ound that site-selective single or double attachment of glycan antigens is sufficient to induce high levels of anti-OAg IgG antibodies with serum bactericidal activity.T he coupling site of the saccharide to one defined point on the carrier protein affected the elicited immune response.T he use of such highly selective chemical methods has advantages in terms of consistency of production and characterization, and allows abetter investigation of the immunological mechanism of glycoconjugate vaccines. . .

